Literature DB >> 6386863

Successive extraction of specific protective immunoglobulins from pooled human sera.

K Yoshida, Y Ichiman.   

Abstract

By use of pooled human sera, specific protective immunoglobulins against the Smith-diffuse strain of Staphylococcus aureus, strains SS-620 and SS-619 of types III and II group B streptococci, and strain K-9 of Klebsiella pneumoniae were successively extracted from their whole cell and antibody complexes by elution with propionic acid containing 5% sucrose. Injection of 0.14, 0.05, 0.09, and 0.15 mg of these eluates in mice gave protection against lethal infection only with homologous strains. However, no protective effect was observed against these infections, even with considerably higher amounts of a conventional immunoglobulin preparation. The major components of the eluates were the three major immunoglobulins, immunoglobulin G (IgG), IgA, and IgM, although nonspecific proteins were also included. Protective activities of these eluates were absorbed out by their protection-inducing antigens, indicating that they contained specific protective immunoglobulins.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6386863      PMCID: PMC271350          DOI: 10.1128/jcm.20.3.461-464.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Specific heterophile antibody from infectious mononucleosis serum.

Authors:  K Yoshida; A Nahmias
Journal:  Proc Soc Exp Biol Med       Date:  1967-02

2.  Type-specific polysaccharide antigens of group B streptococci.

Authors:  R C Lancefield; E H Freimer
Journal:  J Hyg (Lond)       Date:  1966-06

3.  [Characterization of protective activity in human sera against infection with Klebsiella ozaenae].

Authors:  S Iwami
Journal:  Nihon Ika Daigaku Zasshi       Date:  1983-04

4.  Antibody response to Staphylococcus aureus in rabbits: sequence of immunoglobulin synthesis and its correlation with passive protection in mice.

Authors:  K Yoshida; R D Ekstedt
Journal:  J Bacteriol       Date:  1968-11       Impact factor: 3.490

5.  Demonstration of Serologically Different Capsular Types Among Strains of Staphylococcus aureus by the Serum-Soft Agar Technique.

Authors:  K Yoshida
Journal:  Infect Immun       Date:  1971-04       Impact factor: 3.441

6.  Antibody to group B Streptococcus type III in human sera measured by a mouse protection test.

Authors:  R S Baltimore; C J Baker; D L Kasper
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

7.  Passive protection by human serum in mice infected with encapsulated Staphylococcus aureus.

Authors:  K Yoshida; Y Ichiman; S Narikawa; M Takahashi; E Kono; C L San Clemente
Journal:  J Med Microbiol       Date:  1979-08       Impact factor: 2.472

8.  Human serum bactericidal activity against Serratia marcescens: failure of human, "natural," specific anti-O IgG antibodies to enhance serum bactericidal activity.

Authors:  W H Traub
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1981

9.  Cross protection in mice with the Smith diffuse stain of Staphylococcus aureus versus a type Ia strain of group B streptococci.

Authors:  Y Ichiman; K Yoshida
Journal:  Can J Microbiol       Date:  1982-07       Impact factor: 2.419

10.  Isolation and properties of a surface antigen of Staphylococcus aureus.

Authors:  S I MORSE
Journal:  J Exp Med       Date:  1962-02-01       Impact factor: 14.307

View more
  3 in total

1.  Passive protection by human sera in mice against challenge with strains of group B streptococci.

Authors:  Y Ichiman; K Yoshida
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

2.  Human specific immunoglobulin protects against infection with common Staphylococcus in mice.

Authors:  K Yoshida; Y Ichiman; Y Ohshima
Journal:  Experientia       Date:  1987-03-15

3.  MF59- and Al(OH)3-Adjuvanted Staphylococcus aureus (4C-Staph) Vaccines Induce Sustained Protective Humoral and Cellular Immune Responses, with a Critical Role for Effector CD4 T Cells at Low Antibody Titers.

Authors:  Elisabetta Monaci; Francesca Mancini; Giuseppe Lofano; Marta Bacconi; Simona Tavarini; Chiara Sammicheli; Letizia Arcidiacono; Monica Giraldi; Bruno Galletti; Silvia Rossi Paccani; Antonina Torre; Maria Rita Fontana; Guido Grandi; Ennio de Gregorio; Giuliano Bensi; Emiliano Chiarot; Sandra Nuti; Fabio Bagnoli; Elisabetta Soldaini; Sylvie Bertholet
Journal:  Front Immunol       Date:  2015-09-07       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.